Stock Market Rally Wins In Landslide, Nvidia In Buy Range

insider trading

A powerful stock market rally has taken hold, fueled by election results despite surging coronavirus cases. The Dow Jones, S&P 500 index and Nasdaq composite just had their best weeks since early April after their worst weeks since the March crash. Leading stocks are breaking out in droves.

Joe Biden has won the presidential race, according to the Associated Press, CNN, ABC and CBS. While automatic recounts are likely in at least Pennsylvania and Georgia, with President Donald Trump sure to pursue legal challenges, the 2020 election appears to be over. But not for the Senate. The GOP looks set to hold 50 seats, but could cling to a majority if it wins at least one of two runoff races in Georgia on Jan. 5.

Investors should be looking at expanding exposure, as the new market rally gains momentum. Alibaba stock, Nvidia (NVDA), Google parent Alphabet (GOOGL) are still in range from proper buy points. Use the weekend to prepare for a key week.

Biogen stock is likely to crash Monday. On Wednesday, Biogen (BIIB) spiked as FDA documents raised approval hopes. But on Friday, an FDA panel overwhelmingly opposed recommending its Alzheimer’s drug aducanumab for approval.

Tesla (TSLA) and China electric car makers Nio (NIO), Xpeng Motors (XPEV), Li Auto (LI), BYD Group (BYDFF) have news pending. Tesla stock jumped last week, but remains below a buy point. Nio stock, Xpeng, Li Auto and BYD are all greatly extended after massive weekly gains.

Alibaba (BABA), Tesla and Nvidia stock are on IBD Leaderboard. Alibaba stock is on IBD Long-Term Leaders. Nvidia stock and Alibaba are on the IBD 50. Nvidia and Tesla stock are on the Big Cap 20.

Dow Jones Futures Today
Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq 100 futures. A huge drop in Biogen stock could weigh on the S&P 500 and Nasdaq.

With the 2020 election seemingly coming to a close at the presidential level, that provides further certainty. But investors appear to have priced in the likelihood of a Biden presidency and GOP Senate.

Remember that overnight action in Dow futures and elsewhere doesn’t necessarily translate into actual trading in the next regular stock market session.

Coronavirus cases worldwide reached 50.25 million. Covid-19 deaths topped 1.25 million.

Coronavirus cases in the U.S. have hit 10.18 million, with deaths above 243,000.

On Friday, new coronavirus cases totaled 623,261 worldwide and 132,540 in the U.S., both fresh highs. U.S. Covid cases were more than 124,000 on Saturday, topping 100,000 for a fourth straight day.

Texas has topped one million Covid-19 cases. U.S. coronavirus deaths are picking up, but still well below their spring peaks.

President Donald Trump’s chief of staff, Mark Meadows, has tested positive for the coronavirus.

European coronavirus cases continue to spiral higher, even as many countries have imposed partial lockdowns to counter the spread.

Pfizer (PFE) and BioNTech (BNTX) could announce interim efficacy data from their final-stage coronavirus trial any day, with a possible filing for FDA emergency approval late this month. Moderna (MRNA) could follow with its Covid vaccine candidate in December, with AstraZeneca (AZN) a few weeks later. Several other potential coronavirus vaccines are moving ahead in clinical trials.

The Dow Jones Industrial Average leapt 6.9% in last week’s stock market trading. The S&P 500 index vaulted 7.3%. The Nasdaq composite leapt 9%.

The Dow Jones and S&P 500 index marked follow-through days on Wednesday, confirming the new stock market rally. On Thursday, the Nasdaq followed through.

Growth stocks had a tremendous week.

Among the best ETFs, the Innovator IBD 50 ETF (FFTY) jumped 9.9%. The iShares Expanded Tech-Software Sector ETF (IGV) soared 9.6%. The VanEck Vectors Semiconductor ETF (SMH) leapt 9.9%, with Nvidia stock a major component.

Tech Giants In Buy Zones
Nvidia shot up 16.2%, breaking out past a 574.04 cup-with-handle buy point, according to MarketSmith analysis. That’s after offering an early buy point on Wednesday. NVDA stock was Friday’s IBD Stock Of The Day.

Google stock “only” rose 8.9%, clearing a 1,726.20 buy point from a cup base. But that followed a slim 1% loss the prior week and a 4.2% gain before that, while most stocks were skidding lower in late October.

Alibaba stock fell 1.6% last week, but finished strong. Shares tumbled 8.3% on Tuesday as China suspended the blockbuster IPO for Ant Group, one-third owned by Alibaba. But BABA stock slashed losses, reclaiming its 50-day line and closing right on its 21-day exponential moving average, at 299.95. That also was back above Alibaba’s still-valid 299.10 buy point from a flat base that’s part of a base-on-base formation — actually a base-on-base-on-base.

The Big Picture: Why Q4 Still Looks Bullish For Stock Pickers

China EV Sales
China will report October electric car sales overall and for individual EV makers such as Nio, Xpeng Motors, Li Auto, BYD Group and, of course, Tesla. Nio, Xpeng, Li Auto and BYD all reported strong October deliveries last week, but not Tesla.

There are signs that local Tesla sales jumped, following yet another price cut. The Xpeng P7 and BYD Han EV are both Model 3 rivals. Still, Tesla has started exporting made-in-China Model 3 cars to Europe, providing further evidence that Shanghai production capacity far exceeds domestic demand.

Xpeng earnings are due Thursday. Last week, Xpeng stock exploded for an 80% gain, vaulted past an IPO base. Li Auto, which broke out the prior week, leapt 31%. Nio stock spiked 36%. BYD stock, which trades over the counter in the U.S., ran up 25%, its sixth straight weekly gain.

By comparison, Tesla stock seemed stuck in the slow lane, but it did leap 11% to 429.95. Shares moved back above their 50-day and broke a short downtrend, so arguably that’s an early entry. But investors might want to wait for a little more power, especially with so many other growth stocks flashing so much strength. The official Tesla stock buy point is 466.

Biogen Alzheimer’s Drug Panned
An FDA advisory panel on Friday harshly criticized the Biogen Alzheimer’s drug aducanumab. While the FDA doesn’t have to follow an advisory committee’s lead, the odds of the Biogen drug winning approval seem remote. That’s a huge shift from Wednesday, when FDA briefing documents played up the Alzheimer’s drug, sending Biogen stock up a whopping 44%.

Biogen stock was halted all day Friday. It seems inevitable that BIIB stock will fall Monday, and hard. The only question is how far.

The Best Funds Are Scooping Up These Stocks

Stock Market Rally Analysis
What a difference a week makes. At the end of October, the major indexes and leading stocks had been pulling back for weeks, undercutting their 50-day lines. The post-earnings sell-offs by Apple (AAPL), (AMZN) and Facebook (FB) on Oct. 30 were the final straw, capping the major indexes’ worst week since March and pushing the market into a correction.

Last week started off with decent gains on Monday and Tuesday. But a two-day win streak is hardly a proven stock market rally. Plus, Tuesday was Election Day, with plenty of uncertainty over election results and how investors would react.

It didn’t take long for Wall Street to decide. Even with the election results still somewhat cloudy, the major indexes and leading stocks surged powerfully on Wednesday.

The Dow Jones, S&P 500 index and Nasdaq composite all broke their recent downtrends Wednesday, while the latter two indexes closed convincingly above their 50-day lines. Xpeng stock and Alibaba rivals (JD) and Pinduoduo (PDD) were among the breakouts. Nvidia stock and many others flashed early entries by clearing their 50-day lines and breaking downtrends.

Wednesday’s big gains on higher volume qualified as a follow-through day for the Dow and S&P 500. Because the two indexes closed in the upper half of their daily ranges on Friday, Oct. 30, that qualified as a “pink rally day.” So On Thursday, the stock market rally showed no let up, with further sharp gains for the major indexes and leading stocks. Now the Nasdaq confirmed its rally attempt.

On Friday, the stock market rally fell back early, but slashed losses. The Nasdaq closed slightly higher. Many leading stocks were rushing higher even as the indexes were at session lows. A few more stocks such as Nvidia broke out while prior breakouts advanced or held up.

What’s Next For Market Rally?
The S&P 500 and Nasdaq are just below their October peaks and September all-time highs. Perhaps the stock market rally will rush past those levels. But they could serve as a resistance area for a time. That would let more leaders form handles or move into position.

A modest pullback would be fine. But the Dow or S&P 500 closing below the low of their Wednesday’s follow-through days would be a bad sign for the market rally.

With the election results coming into focus with Joe Biden’s apparent victory, some major uncertainty is lifting. But earnings will still be heavy for the next few weeks. Investors may pay more attention to skyrocketing coronavirus cases, with looming vaccine news offering possible hope or disappointment. Finally, “stimulus deal” headlines could once again swing the market rally.


Leave a Reply

Your email address will not be published.